Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and BHP founder-member the University of Birmingham have signed a licensing agreement to commercialise a … Continue reading “Birmingham to commercialise anti-viral nasal spray against COVID-19”
Year: 2021
Charitable gift to help revolutionise surgical care for children with cancer
Young oncology patients at BHP members Birmingham Children’s Hospital will be able to benefit from a revolutionary type of augmented reality surgery, thanks to a gift from The Azaylia Foundation. … Continue reading “Charitable gift to help revolutionise surgical care for children with cancer”
New drug treatment regimen shows promise for patients with lupus
The results of a randomised controlled trial, published inĀ Annals of Internal Medicine, found that a new drug treatment regimen – using belimumab soon after rituximab – reduced a disease-related autoantibody … Continue reading “New drug treatment regimen shows promise for patients with lupus”
Contraceptive pill can reduce type 2 diabetes risk in women with polycystic ovary syndrome
A study led by BHP founder-member the University of Birmingham has revealed for the first time that the contraceptive pill can reduce the risk of type 2 diabetes by over … Continue reading “Contraceptive pill can reduce type 2 diabetes risk in women with polycystic ovary syndrome”
Specific cell population plays key role in effect of arthritis and people’s pain
Research led by scientists at BHP founder-member the University of Birmingham has identified a new specific population of cells that plays a key role in the affect arthritis has on … Continue reading “Specific cell population plays key role in effect of arthritis and people’s pain”